wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38392673-08B437BC-6303-43B3-B70E-C6E30F738FC5
Q38392673-08B437BC-6303-43B3-B70E-C6E30F738FC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392673-08B437BC-6303-43B3-B70E-C6E30F738FC5
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.
P2860
Q38392673-08B437BC-6303-43B3-B70E-C6E30F738FC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38392673-08B437BC-6303-43B3-B70E-C6E30F738FC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c5f93c7e83bbd650ae488e2becb24e1779524d4
P2860
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.